跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 505 条关于
“Wilson Sonsini”
全部
505
临床试验
283
药物
14
机构
34
资讯
174
去年
Concentra Biosciences to Acquire Allakos for $0.33 Per Share in Strategic Biotech Deal
3个月前
Lilly Acquires 4E Therapeutics to Advance Non-Opioid MNK Inhibitor Pipeline for Chronic Pain
去年
Xaira Therapeutics Appoints Jeff Jonker as President and COO to Scale AI-Driven Drug Discovery Platform
9个月前
Aeovian Pharmaceuticals Secures $55 Million Series B to Advance First-in-Class mTORC1 Inhibitor for Rare Epilepsy
5个月前
Neurocrine Biosciences Acquires Soleno Therapeutics for $2.9 Billion, Adding First-in-Class PWS Treatment
去年
Eton Pharmaceuticals Launches FDA-Approved Galzin for Wilson Disease Maintenance Treatment
去年
Monopar's ALXN1840 Shows Sustained Neurological Benefits in Long-Term Wilson Disease Study
11天前
Orphalan Initiates Global Phase 3 TRADITiONAL Study of Once-Daily Trientine in Wilson Disease
去年
ALXN1840 Shows Promising Long-Term Efficacy and Safety for Wilson Disease at EASL 2025
6个月前
Monopar Therapeutics Strengthens Leadership Team Ahead of ALXN1840 NDA Submission for Wilson Disease
第 1 页,共 18 页
上一页
下一页